Free Trial
LON:SLN

Silence Therapeutics (SLN) Share Price, News & Analysis

Silence Therapeutics logo

About Silence Therapeutics Stock (LON:SLN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
535
535
52-Week Range
N/A
Volume
913,528 shs
Average Volume
80,100 shs
Market Capitalization
£480.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SLN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silence Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SLN Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
20 Takeover Rumors Hedge Funds Are Buying
See More Headlines

SLN Stock Analysis - Frequently Asked Questions

Silence Therapeutics plc (LON:SLN) posted its quarterly earnings results on Monday, September, 14th. The company reported ($13.70) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($21.70) by $8.00.

Shares of SLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Silence Therapeutics investors own include Arch Therapeutics (ARTH), QuickLogic (QUIK), Asiamet Resources (ARS), ArcBest (ARCB), American Renal Associates (ARA), Apergy (APY) and Anchiano Therapeutics (ANCN).

Company Calendar

Last Earnings
9/14/2020
Today
7/13/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:SLN
CIK
N/A
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.80
Current Ratio
4.52
Quick Ratio
4.36

Sales & Book Value

Annual Sales
£11.35 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
6.34
Book Value
GBX 18.20 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
89,785,000
Free Float
N/A
Market Cap
£480.35 million
Optionable
Not Optionable
Beta
N/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:SLN) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners